Personal information

Emails & domains

Verified email domains

Other IDs

SciProfiles: 1306706
Scopus Author ID: 6506935067

Keywords

Tumor metabolism, Immunometabolism, Drug resistance

Countries

United States

Activities

Collapse all

Employment (2)

Miami VA Healthcare System: Miami, Florida, US

Research Scientist/Associate Professor (Surgery)
Employment
Source: Self-asserted source
Medhi Wangpaichitr

Leonard M. Miller School of Medicine, University of Miami: FL, FL, US

Associate Professor (Surgery)
Employment
Source: Self-asserted source
Medhi Wangpaichitr

Professional activities (3)

The Scientific Research Honor Society: Durham, US

Membership
Source: Self-asserted source
Medhi Wangpaichitr

CDMRP: Frederick, US

Membership
Source: Self-asserted source
Medhi Wangpaichitr

American Association for Cancer Research: PA, PA, US

Membership
Source: Self-asserted source
Medhi Wangpaichitr

Funding (3)

Development of new therapies for cancer and other diseases and conditions using analogs of growth hormone-releasing hormones (GHRH)

2020-04-01 to 2024-09-30 | Grant
United States Department of Veterans Affairs (Washington D.C., US)
URL: https://app.dimensions.ai/details/grant/grant.9212788
GRANT_NUMBER: I01BX005051
Source: Self-asserted source
Medhi Wangpaichitr via DimensionsWizard

Hi-jacking the kynurenine pathway: A new path used by cisplatin resistant non-small cell lung cancer to survive and evade immune surveillance under high ROS

2018-07-01 to 2022-06-30 | Grant
United States Department of Veterans Affairs (Washington D.C., US)
URL: https://app.dimensions.ai/details/grant/grant.7614633
GRANT_NUMBER: I01BX004371
Source: Self-asserted source
Medhi Wangpaichitr via DimensionsWizard

Metabolic reprogramming: A new paradigm for targeting cisplatin resistant cells

2012-10-01 to 2017-09-30 | Grant
United States Department of Veterans Affairs (Washington D.C., US)
URL: https://app.dimensions.ai/details/grant/grant.2402571
GRANT_NUMBER: IK2BX001289
Source: Self-asserted source
Medhi Wangpaichitr via DimensionsWizard

Peer review (5 reviews for 4 publications/grants)

Review activity for BMC complementary medicine and therapies. (1)
Review activity for Cell death and disease. (1)
Review activity for Clinical & translational oncology. (1)
Review activity for Communications biology. (2)
How many people are using ORCID?